SELLAS Life Sciences Group, Inc. (SLS)
3.55
-0.12
(-3.27%)
USD |
NASDAQ |
Feb 12, 16:00
3.55
0.00 (0.00%)
Pre-Market: 09:24
SELLAS Life Sciences Group Free Cash Flow : -30.62M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| GT Biopharma, Inc. | -11.36M |
| Amicus Therapeutics, Inc. | 9.691M |
| Geron Corp. | -132.68M |
| Vanda Pharmaceuticals, Inc. | -82.95M |
| ADMA Biologics, Inc. | 40.61M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -7.068M |
| Cash from Financing (Quarterly) | 26.09M |
| Free Cash Flow Per Share (Quarterly) | -0.0652 |
| Free Cash Flow to Equity (Quarterly) | -6.93M |
| Free Cash Flow to Firm (Quarterly) | -7.068M |
| Free Cash Flow Yield | -9.36% |